Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

J. Smolders, R. Hupperts, F. Barkhof, L.M.E. Grimaldi, T. Holmoy, J. Killestein, P. Rieckmann, M. Schluep, R. Vieth, U. Hostalek, L. Ghazi-Visser, M. Beelke

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)44-49
JournalJournal of the Neurological Sciences
Volume311
Issue number1-2
DOIs
Publication statusPublished - 2011

Cite this